Early medical abortion using low‐dose mifepristone followed by buccal misoprostol: a large Australian observational study

Abstract

Mifepristone, with buccal misoprostol self-administered at home, for EMA up to 63 days of gestation had a low failure rate, was well accepted, and provided an effective treatment option with a favourable safety profile for women seeking an abortion in Australia.